Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621976 | SCV000736550 | uncertain significance | Cardiovascular phenotype | 2019-08-23 | criteria provided, single submitter | clinical testing | The p.C9553R variant (also known as c.28657T>C), located in coding exon 115 of the TTN gene, results from a T to C substitution at nucleotide position 28657. The cysteine at codon 9553 is replaced by arginine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species, and arginine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000764326 | SCV000895345 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003139941 | SCV003819651 | uncertain significance | not provided | 2020-03-03 | criteria provided, single submitter | clinical testing |